Developing better tools for studying polycystic kidney disease
Antibody Validation Vector Core
This study is working on creating better tools to help scientists understand polycystic kidney disease (PKD) so they can learn more about how the disease affects the body and eventually improve treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10886671 on NIH RePORTER |
What this research studies
This research focuses on improving the understanding of polycystic kidney disease (PKD) by developing high-quality antibodies and expression constructs that can be used in laboratory studies. Researchers will create and validate these tools to help identify the cellular pathways affected by mutations in PKD genes. By utilizing advanced biotechnology, the project aims to enhance the accuracy and effectiveness of experiments conducted in cell culture systems and animal models, ultimately paving the way for clinical trials. The goal is to provide a robust toolkit that supports ongoing investigations into PKD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with polycystic kidney disease or those at risk of developing it.
Not a fit: Patients with other unrelated kidney diseases or conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective therapies for patients with polycystic kidney disease.
How similar studies have performed: Other research has shown success in developing innovative tools for studying complex diseases, indicating that this approach has the potential for significant advancements.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Qian, Feng — University of Maryland Baltimore
- Study coordinator: Qian, Feng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.